Autonomic Nervous System Drugs Practice Questions

Q: Which of the following is NOT true about succinylcholine (scoline)?

Is a non-depolarizing neuromuscular blocker. **Explanation:** Succinylcholine (Scoline) is the only **depolarizing neuromuscular blocker** used clinically. It works by mimicking acetylcholine at the nicotinic receptors of the motor endplate, causing persistent depolarization that prevents further muscle contraction. Therefore, Option C is incorrect (and the right answer) because it is not a non-depolarizing agent (like vecuronium or rocuronium). **Analysis of other options:** * **Option A (Fasciculations):** Before causing paralysis, succinylcholine causes disorganized muscle contractions known as fasciculations. This is a hallmark of depolarizing blocks. * **Option B (Increased Pressures):** Succinylcholine transiently increases **Intraocular Pressure (IOP)**, Intragastric Pressure, and Intracranial Pressure (ICP). This makes its use controversial in penetrating eye injuries or severe head trauma. * **Option D (Short-acting):** It has the fastest onset (30–60 seconds) and the shortest duration of action (5–10 minutes) among all relaxants, making it the drug of choice for **Rapid Sequence Induction (RSI)**. **High-Yield Clinical Pearls for NEET-PG:** 1. **Metabolism:** It is metabolized by **Pseudocholinesterase** (Plasma cholinesterase). Deficiency of this enzyme leads to prolonged apnea (Scoline Apnea). 2. **Hyperkalemia:** It can cause a rise in serum potassium (~0.5 mEq/L). It is strictly contraindicated in patients with burns, massive trauma, or upper motor neuron lesions due to the risk of fatal hyperkalemia. 3. **Malignant Hyperthermia:** Succinylcholine is a potent trigger for Malignant Hyperthermia (Treatment: Dantrolene). 4. **Side Effects:** Post-operative myalgia is a common complaint following its use.

Q: Maximum histamine release is associated with which neuromuscular blocking agent?

D-Tubocurarine. **Explanation:** **D-Tubocurarine (DTC)** is the correct answer because it is a benzylisoquinolinium compound known for causing the most significant non-immunological (direct) release of histamine from mast cells. This histamine release often leads to clinical manifestations such as hypotension, flushing, tachycardia, and bronchospasm. Due to this side effect profile and the availability of safer alternatives, its clinical use has largely been phased out. **Analysis of Incorrect Options:** * **Succinylcholine:** While it is a depolarizing blocker that can cause various side effects (hyperkalemia, fasciculations, malignant hyperthermia), it is not associated with significant histamine release. * **Pancuronium:** An aminosteroid muscle relaxant. It does not cause histamine release; instead, it has **vagolytic effects**, leading to tachycardia and hypertension. * **Gallamine:** An older non-depolarizing agent that primarily causes tachycardia due to its strong antimuscarinic (vagolytic) action, but it does not trigger significant histamine release compared to DTC. **High-Yield Clinical Pearls for NEET-PG:** * **Histamine Release Ranking:** D-Tubocurarine > Mivacurium > Atracurium. (Modern aminosteroids like Vecuronium and Rocuronium are virtually free of histamine release). * **Drug of Choice for Asthmatics:** Avoid DTC and Atracurium (due to histamine-induced bronchospasm). **Vecuronium** or **Rocuronium** are preferred. * **Hoffman Elimination:** Remember that **Atracurium** and **Cisatracurium** undergo spontaneous degradation (Hoffman elimination), making them safe in renal and hepatic failure. * **Laudanosine Toxicity:** A metabolite of Atracurium that can cross the BBB and cause seizures.

Q: Which neuromuscular blocker does not require reversal of its action by neostigmine at the end of the operation?

Mivacurium. **Explanation:** The correct answer is **Mivacurium (Option C)**. **Why Mivacurium is the correct answer:** Mivacurium is a short-acting, non-depolarizing neuromuscular blocker (NMB). Its unique pharmacokinetic profile is defined by its rapid metabolism by **plasma pseudocholinesterase** (butyrylcholinesterase), similar to succinylcholine. Because it is inactivated so quickly by enzymes naturally present in the blood, its effects wear off spontaneously within 15–20 minutes. Therefore, pharmacological reversal with an acetylcholinesterase inhibitor like **Neostigmine** is often unnecessary, as the natural recovery is rapid. **Analysis of Incorrect Options:** * **Pipecuronium (A) & Doxacurium (D):** These are **long-acting** benzylisoquinolinium/aminosteroid compounds. They have a slow onset and a very long duration of action (often >60–90 minutes). They require active reversal with neostigmine to ensure adequate respiratory function post-surgery. * **d-Tubocurarine (B):** This is the prototype **long-acting** non-depolarizing NMB. It is rarely used today due to its side effect profile (histamine release and ganglion blockade) and always requires reversal due to its prolonged duration. **High-Yield Clinical Pearls for NEET-PG:** * **Shortest acting non-depolarizing NMB:** Mivacurium. * **Shortest acting NMB overall:** Succinylcholine (Depolarizing). * **Hoffman Elimination:** Remember that **Atracurium** and **Cisatracurium** undergo spontaneous degradation (Hoffman elimination) and are the drugs of choice in patients with liver or kidney failure. * **Neostigmine Mechanism:** It works by inhibiting acetylcholinesterase, increasing ACh levels at the NMJ to outcompete the non-depolarizing blocker. It is always co-administered with **Glycopyrrolate** or Atropine to prevent muscarinic side effects (bradycardia).

Q: Succinylcholine can cause which of the following electrolyte imbalances?

Hyperkalemia. **Explanation:** **Succinylcholine** is a depolarizing neuromuscular blocking agent that acts as an agonist at the nicotinic acetylcholine receptors (nAChR) at the motor endplate. **Why Hyperkalemia occurs (The Correct Answer):** When Succinylcholine binds to the nAChR, it causes prolonged depolarization of the muscle membrane. This process opens ion channels, allowing sodium to flow into the cell and **potassium to flow out of the muscle cell into the extracellular fluid (ECF)**. In a healthy individual, this typically results in a transient, modest rise in serum potassium levels (approximately **0.5 mEq/L**). However, in certain pathological states (e.g., burns, massive trauma, or denervation injuries), there is an "upregulation" of extrajunctional receptors, leading to an exaggerated release of potassium that can cause life-threatening cardiac arrhythmias. **Why other options are incorrect:** * **Hypokalemia:** Succinylcholine causes the efflux of potassium from cells, which increases serum levels. It does not cause potassium to move into cells or increase its excretion, so hypokalemia is not a side effect. * **Both/None:** Since the mechanism specifically facilitates potassium release into the bloodstream, the effect is unidirectional toward hyperkalemia. **High-Yield Clinical Pearls for NEET-PG:** * **The "0.5 Rule":** Expect a 0.5 mEq/L rise in serum $K^+$ in normal patients. * **Contraindications:** Avoid Succinylcholine in patients with **major burns (>24-48 hours old)**, crush injuries, spinal cord injuries (paraplegia/quadriplegia), and muscular dystrophies (due to risk of rhabdomyolysis). * **Other Side Effects:** Fasciculations, muscle pain (myalgia), increased intraocular pressure, increased intracranial pressure, and it is a known trigger for **Malignant Hyperthermia**.

Q: A drug is shown to activate dopaminergic D1 and D2 and adrenergic α and β1 but not β2 receptors. Which of the following can be the drug being talked about?

Dopamine. ### Explanation **1. Why Dopamine is Correct:** Dopamine is a unique catecholamine that exhibits **dose-dependent receptor activation**. Its pharmacological profile perfectly matches the question: * **Low dose (0.5–2 µg/kg/min):** Primarily acts on **D1 and D2 receptors** in the renal and mesenteric vasculature, causing vasodilation. * **Medium dose (2–10 µg/kg/min):** Stimulates **β1 receptors** in the heart, increasing contractility and cardiac output. * **High dose (>10 µg/kg/min):** Activates **α1 receptors**, leading to systemic vasoconstriction. Crucially, Dopamine has **no significant action on β2 receptors**, which distinguishes it from Epinephrine. **2. Why Other Options are Incorrect:** * **Dobutamine:** It is a relatively selective **β1 agonist** with minor β2 and α1 activity. It lacks dopaminergic (D1/D2) activity. It is primarily used as an inotrope in cardiogenic shock. * **Methoxamine:** This is a selective **α1 agonist**. It has no action on β or dopamine receptors. It is rarely used clinically today but was historically used to treat paroxysmal supraventricular tachycardia (PSVT) via reflex bradycardia. * **Phenylephrine:** A selective **α1 agonist**. Like methoxamine, it lacks β and dopamine receptor activity. It is commonly used as a nasal decongestant and to maintain blood pressure during spinal anesthesia. **3. High-Yield Clinical Pearls for NEET-PG:** * **Fenoldopam:** A selective **D1 agonist** used in hypertensive emergencies; it maintains renal perfusion while lowering BP. * **Dopamine in Shock:** While historically popular, it is now often second-line to Norepinephrine in septic shock due to a higher risk of arrhythmias. * **Renal Dose Myth:** Low-dose dopamine increases urine output but has **not** been proven to improve survival or prevent acute renal failure in clinical trials. * **Receptor Mnemonic:** Remember the order of activation as **D → β → α** as the dose increases.

Q: Which of the following systems is most sensitive to atropine?

Respiratory mucosa. **Explanation:** The sensitivity of different organs to atropine follows a predictable, dose-dependent hierarchy. This is a classic high-yield concept in pharmacology known as the **"Order of Atropine Sensitivity."** **1. Why Respiratory Mucosa is Correct:** Atropine is highly potent at inhibiting secretions. The **salivary, sweat, and bronchial (respiratory) glands** are the most sensitive to muscarinic blockade. Even at very low doses (0.5 mg), atropine effectively causes dryness of the mouth and suppression of respiratory tract secretions. This is why it is used as a pre-anesthetic medication to prevent laryngospasm and aspiration. **2. Analysis of Incorrect Options:** * **Heart (B):** The heart is moderately sensitive. Low doses may cause paradoxical bradycardia (due to presynaptic M1 blockade), while higher doses are required to produce the characteristic tachycardia (M2 blockade). * **Pupil (C):** The eye (causing mydriasis and cycloplegia) requires higher doses than those needed to suppress secretions. * **Gastrointestinal Motility (D):** The GI tract and urinary bladder are the **least sensitive** to atropine. Significant inhibition of gastric acid secretion and intestinal motility requires very high doses, which often lead to intolerable side effects (like severe dry mouth and blurred vision). **3. NEET-PG High-Yield Pearls:** * **Order of Sensitivity (Highest to Lowest):** Salivary/Sweat/Bronchial Glands > Eye/Heart > GI tract/Bladder > Gastric Parietal cells. * **Mnemonic:** "Secretions first, Stomach last." * **Clinical Application:** Atropine is the drug of choice for **Organophosphate poisoning** (to reverse muscarinic effects) and **Early Mushroom poisoning**. * **Contraindication:** Avoid in patients with **Glaucoma** (increases intraocular pressure) and **Prostatic Hyperplasia** (causes urinary retention).

Q: Cholinesterase inhibitors cause all of the following effects, except:

Bronchodilation. **Explanation:** Cholinesterase inhibitors (e.g., Neostigmine, Physostigmine) work by inhibiting the enzyme acetylcholinesterase, leading to an accumulation of **Acetylcholine (ACh)** at the synaptic cleft. This results in generalized stimulation of the parasympathetic nervous system (muscarinic effects). **Why Bronchodilation is the Correct Answer:** ACh acts on **M3 receptors** located in the bronchial smooth muscle. Stimulation of these receptors causes **bronchoconstriction** and increased tracheobronchial secretions. Therefore, cholinesterase inhibitors cause bronchospasm, not bronchodilation. Bronchodilation is a sympathetic (adrenergic) response or a result of anticholinergic drugs (like Ipratropium). **Analysis of Incorrect Options:** * **A. Increased salivation:** ACh stimulates M3 receptors on salivary glands, leading to profuse watery secretions (Sialorrhea). * **C. Constricted pupils:** ACh acts on the sphincter pupillae muscle of the iris (M3 receptors), causing **miosis** (constriction). * **D. Increased peristalsis:** ACh increases the tone and motility of the GI tract smooth muscles and relaxes sphincters, promoting defecation and peristalsis. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Cholinergic Excess:** **DUMBELS** (Diarrhea, Urination, Miosis, Bronchospasm/Bradycardia, Emesis, Lacrimation, Salivation). * **Clinical Contraindication:** Cholinesterase inhibitors should be avoided in patients with **Bronchial Asthma** or COPD due to the risk of severe bronchoconstriction. * **Drug of Choice:** Atropine (an antimuscarinic) is the physiological antagonist used to reverse these muscarinic effects in organophosphate poisoning.

Q: Cholinergic drugs such as pilocarpine are routinely used to treat glaucoma. What is their mechanism of action in the eye that accounts for this ophthalmologic use?

Improved drainage of aqueous humor. **Explanation:** Pilocarpine is a direct-acting parasympathomimetic (cholinergic) drug. Its primary mechanism in treating glaucoma involves the stimulation of **muscarinic (M3) receptors** on the **sphincter pupillae** and the **ciliary muscle**. 1. **Why Option D is Correct:** When the ciliary muscle contracts, it pulls on the **scleral spur**. This mechanical action opens up the pores of the **trabecular meshwork**, thereby increasing the outflow (drainage) of aqueous humor into the Canal of Schlemm. In angle-closure glaucoma, the induced miosis (pupillary constriction) also pulls the peripheral iris away from the trabecular meshwork, opening the anatomical angle. 2. **Why Incorrect Options are Wrong:** * **Option A:** Reduction of aqueous formation is the mechanism of **Beta-blockers** (e.g., Timolol), **Alpha-2 agonists** (e.g., Brimonidine), and **Carbonic Anhydrase Inhibitors** (e.g., Acetazolamide). * **Option B:** Pilocarpine is a cholinergic agonist, not an adrenergic blocker. Adrenergic blockade (Beta-blockers) reduces production rather than potentiating cholinergic drainage. * **Option C:** The pH of aqueous humor is not the therapeutic target for glaucoma drugs; alkalinization does not lower intraocular pressure. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Pilocarpine is the drug of choice for **Acute Angle Closure Glaucoma** (to break the attack after initial pressure reduction). * **Side Effects:** Brow ache (due to ciliary spasm), induced myopia, and decreased night vision (due to miosis). * **Contraindication:** Avoid in young patients (risk of retinal detachment) and patients with cataracts (miosis further obscures vision).

Q: Which drug inhibits the reuptake of norepinephrine into the presynaptic membrane?

Cocaine. **Explanation:** The correct answer is **Cocaine**. **Mechanism of Action (Correct Option):** Cocaine acts as a potent **indirect-acting sympathomimetic**. Its primary mechanism is the inhibition of the **Norepinephrine Transporter (NET)** located on the presynaptic membrane [1]. By blocking this transporter, cocaine prevents the reuptake of norepinephrine (NE) from the synaptic cleft back into the neuron [2]. This leads to an accumulation of NE in the synapse, resulting in prolonged and intensified stimulation of post-synaptic adrenergic receptors. This explains its systemic effects, such as tachycardia, hypertension, and pupillary dilation (mydriasis). **Analysis of Incorrect Options:** * **Lidocaine and Procaine:** These are local anesthetics that work by blocking **voltage-gated sodium channels** on the neuronal membrane. This prevents depolarization and the conduction of action potentials, providing anesthesia. They do not primarily affect the reuptake of catecholamines. * **Botulinum Toxin:** This toxin acts at the neuromuscular junction by cleaving **SNARE proteins**. This prevents the fusion of synaptic vesicles with the presynaptic membrane, thereby inhibiting the **release of Acetylcholine (ACh)**, leading to flaccid paralysis. **High-Yield Clinical Pearls for NEET-PG:** * **NET vs. VMAT:** While Cocaine blocks the membrane transporter (NET), drugs like **Reserpine** inhibit the Vesicular Monoamine Transporter (VMAT), which stores NE in vesicles [2]. * **Tricyclic Antidepressants (TCAs):** Like cocaine, TCAs also inhibit the reuptake of NE and Serotonin [1]. * **Clinical Contraindication:** Never give **Beta-blockers** alone in cocaine toxicity; unopposed alpha-stimulation can lead to a hypertensive crisis.

Question 1

Which of the following is NOT true about succinylcholine (scoline)?

Accepted Answer

Is a non-depolarizing neuromuscular blocker

Answer

Causes fasciculations

Answer

Increases intraocular pressure (ICT)

Answer

Is a short-acting muscle relaxant

Question 2

Use of phentolamine is of relatively little value in which of the following situations?

Accepted Answer

Treatment of essential hypertension.

Answer

Prevention of hypertension during operative removal of pheochromocytoma.

Answer

Treatment of male sexual dysfunction.

Answer

Treatment of hypertension due to clonidine withdrawal.

Question 3

Maximum histamine release is associated with which neuromuscular blocking agent?

Accepted Answer

D-Tubocurarine

Answer

Succinylcholine

Answer

Pancuronium

Answer

Gallamine

Question 4

Which neuromuscular blocker does not require reversal of its action by neostigmine at the end of the operation?

Accepted Answer

Mivacurium

Answer

Pipecuronium

Answer

d-Tubocurarine

Answer

Doxacurium

Question 5

Succinylcholine can cause which of the following electrolyte imbalances?

Accepted Answer

Hyperkalemia

Answer

Hypokalemia

Answer

Both hypokalemia and hyperkalemia

Answer

None of the above

Question 6

A drug is shown to activate dopaminergic D1 and D2 and adrenergic α and β1 but not β2 receptors. Which of the following can be the drug being talked about?

Accepted Answer

Dopamine

Answer

Dobutamine

Answer

Methoxamine

Answer

Phenylephrine

Question 7

Which of the following systems is most sensitive to atropine?

Accepted Answer

Respiratory mucosa

Answer

Heart

Answer

Pupil

Answer

Gastrointestinal motility

Question 8

Cholinesterase inhibitors cause all of the following effects, except:

Accepted Answer

Bronchodilation

Answer

Increased salivation

Answer

Constricted pupils

Answer

Increased peristalsis

Question 9

Cholinergic drugs such as pilocarpine are routinely used to treat glaucoma. What is their mechanism of action in the eye that accounts for this ophthalmologic use?

Accepted Answer

Improved drainage of aqueous humor

Answer

Reduction in the formation of aqueous humor

Answer

Blockade of adrenergic receptors to potentiate cholinergic effects

Answer

Alkalinization of aqueous humor

Question 10

Which drug inhibits the reuptake of norepinephrine into the presynaptic membrane?

Accepted Answer

Cocaine

Answer

Lidocaine

Answer

Procaine

Answer

Botulinum toxin

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?